Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
Search
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News Releases view all

    • News in Focus
        • Browse News Releases

        • All News Releases
        • All Public Company
        • English-only
        • News Releases Overview

        • Multimedia Gallery

        • All Multimedia
        • All Photos
        • All Videos
        • Multimedia Gallery Overview

        • Trending Topics

        • All Trending Topics
    • Business & Money
        • Auto & Transportation

        • Aerospace, Defense
        • Air Freight
        • Airlines & Aviation
        • Automotive
        • Maritime & Shipbuilding
        • Railroads and Intermodal Transportation
        • Supply Chain/Logistics
        • Transportation, Trucking & Railroad
        • Travel
        • Trucking and Road Transportation
        • Auto & Transportation Overview

        • View All Auto & Transportation

        • Business Technology

        • Blockchain
        • Broadcast Tech
        • Computer & Electronics
        • Computer Hardware
        • Computer Software
        • Data Analytics
        • Electronic Commerce
        • Electronic Components
        • Electronic Design Automation
        • Financial Technology
        • High Tech Security
        • Internet Technology
        • Nanotechnology
        • Networks
        • Peripherals
        • Semiconductors
        • Business Technology Overview

        • View All Business Technology

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Financial Services & Investing

        • Accounting News & Issues
        • Acquisitions, Mergers and Takeovers
        • Banking & Financial Services
        • Bankruptcy
        • Bond & Stock Ratings
        • Conference Call Announcements
        • Contracts
        • Cryptocurrency
        • Dividends
        • Earnings
        • Earnings Forecasts & Projections
        • Financing Agreements
        • Insurance
        • Investments Opinions
        • Joint Ventures
        • Mutual Funds
        • Private Placement
        • Real Estate
        • Restructuring & Recapitalization
        • Sales Reports
        • Shareholder Activism
        • Shareholder Meetings
        • Stock Offering
        • Stock Split
        • Venture Capital
        • Financial Services & Investing Overview

        • View All Financial Services & Investing

        • General Business

        • Awards
        • Commercial Real Estate
        • Corporate Expansion
        • Earnings
        • Environmental, Social and Governance (ESG)
        • Human Resource & Workforce Management
        • Licensing
        • New Products & Services
        • Obituaries
        • Outsourcing Businesses
        • Overseas Real Estate (non-US)
        • Personnel Announcements
        • Real Estate Transactions
        • Residential Real Estate
        • Small Business Services
        • Socially Responsible Investing
        • Surveys, Polls and Research
        • Trade Show News
        • General Business Overview

        • View All General Business

    • Science & Tech
        • Consumer Technology

        • Artificial Intelligence
        • Blockchain
        • Cloud Computing/Internet of Things
        • Computer Electronics
        • Computer Hardware
        • Computer Software
        • Consumer Electronics
        • Cryptocurrency
        • Data Analytics
        • Electronic Commerce
        • Electronic Gaming
        • Financial Technology
        • Mobile Entertainment
        • Multimedia & Internet
        • Peripherals
        • Social Media
        • STEM (Science, Tech, Engineering, Math)
        • Supply Chain/Logistics
        • Wireless Communications
        • Consumer Technology Overview

        • View All Consumer Technology

        • Energy & Natural Resources

        • Alternative Energies
        • Chemical
        • Electrical Utilities
        • Gas
        • General Manufacturing
        • Mining
        • Mining & Metals
        • Oil & Energy
        • Oil and Gas Discoveries
        • Utilities
        • Water Utilities
        • Energy & Natural Resources Overview

        • View All Energy & Natural Resources

        • Environ­ment

        • Conservation & Recycling
        • Environmental Issues
        • Environmental Policy
        • Environmental Products & Services
        • Green Technology
        • Natural Disasters
        • Environment Overview

        • View All Environ­ment

        • Heavy Industry & Manufacturing

        • Aerospace & Defense
        • Agriculture
        • Chemical
        • Construction & Building
        • General Manufacturing
        • HVAC (Heating, Ventilation and Air-Conditioning)
        • Machinery
        • Machine Tools, Metalworking and Metallurgy
        • Mining
        • Mining & Metals
        • Paper, Forest Products & Containers
        • Precious Metals
        • Textiles
        • Tobacco
        • Heavy Industry & Manufacturing Overview

        • View All Heavy Industry & Manufacturing

        • Telecomm­unications

        • Carriers and Services
        • Mobile Entertainment
        • Networks
        • Peripherals
        • Telecommunications Equipment
        • Telecommunications Industry
        • VoIP (Voice over Internet Protocol)
        • Wireless Communications
        • Telecommunications Overview

        • View All Telecomm­unications

    • Lifestyle & Health
        • Consumer Products & Retail

        • Animals & Pets
        • Beers, Wines and Spirits
        • Beverages
        • Bridal Services
        • Cannabis
        • Cosmetics and Personal Care
        • Fashion
        • Food & Beverages
        • Furniture and Furnishings
        • Home Improvement
        • Household, Consumer & Cosmetics
        • Household Products
        • Jewelry
        • Non-Alcoholic Beverages
        • Office Products
        • Organic Food
        • Product Recalls
        • Restaurants
        • Retail
        • Supermarkets
        • Toys
        • Consumer Products & Retail Overview

        • View All Consumer Products & Retail

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Health

        • Biometrics
        • Biotechnology
        • Clinical Trials & Medical Discoveries
        • Dentistry
        • FDA Approval
        • Fitness/Wellness
        • Health Care & Hospitals
        • Health Insurance
        • Infection Control
        • International Medical Approval
        • Medical Equipment
        • Medical Pharmaceuticals
        • Mental Health
        • Pharmaceuticals
        • Supplementary Medicine
        • Health Overview

        • View All Health

        • Sports

        • General Sports
        • Outdoors, Camping & Hiking
        • Sporting Events
        • Sports Equipment & Accessories
        • Sports Overview

        • View All Sports

        • Travel

        • Amusement Parks and Tourist Attractions
        • Gambling & Casinos
        • Hotels and Resorts
        • Leisure & Tourism
        • Outdoors, Camping & Hiking
        • Passenger Aviation
        • Travel Industry
        • Travel Overview

        • View All Travel

    • Policy & Public Interest
        • Policy & Public Interest

        • Advocacy Group Opinion
        • Animal Welfare
        • Congressional & Presidential Campaigns
        • Corporate Social Responsibility
        • Domestic Policy
        • Economic News, Trends, Analysis
        • Education
        • Environmental
        • European Government
        • FDA Approval
        • Federal and State Legislation
        • Federal Executive Branch & Agency
        • Foreign Policy & International Affairs
        • Homeland Security
        • Labor & Union
        • Legal Issues
        • Natural Disasters
        • Not For Profit
        • Patent Law
        • Public Safety
        • Trade Policy
        • U.S. State Policy
        • Policy & Public Interest Overview

        • View All Policy & Public Interest

    • People & Culture
        • People & Culture

        • Aboriginal, First Nations & Native American
        • African American
        • Asian American
        • Children
        • Diversity, Equity & Inclusion
        • Hispanic
        • Lesbian, Gay & Bisexual
        • Men's Interest
        • People with Disabilities
        • Religion
        • Senior Citizens
        • Veterans
        • Women
        • People & Culture Overview

        • View All People & Culture

    • Explore Our Platform
    • Plan Campaigns
    • Create with AI
    • Distribute Press Releases
    • Report Results
    • Amplify Content
    • All Products
    • General Inquiries
    • Editorial Bureaus
    • Partnerships
    • Media Inquiries
    • Worldwide Offices
    • Hamburger menu
    • PR Newswire: news distribution, targeting and monitoring
    • Send a Release
      • ALL CONTACT INFO
      • Contact Us

        888-776-0942
        from 8 AM - 10 PM ET

    • Searching for your content...

      No results found. Please change your search terms and try again.

      News Releases

      view all
      Close menu
    • News
    • Products
    • Contact
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • 3 News in Focus
      • 5 Business & Money
      • 5 Science & Tech
      • 5 Lifestyle & Health
      • 1 Policy & Public Interest
      • 1 People & Culture
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content
      • All Products
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      Close submenu (News in Focus) News in Focus
      • Browse News Releases
      • Multimedia Gallery
      • Trending Topics
      Close submenu (Business & Money) Business & Money
      • Auto & Transportation
      • Business Technology
      • Entertain­ment & Media
      • Financial Services & Investing
      • General Business
      Close submenu (Science & Tech) Science & Tech
      • Consumer Technology
      • Energy & Natural Resources
      • Environ­ment
      • Heavy Industry & Manufacturing
      • Telecomm­unications
      Close submenu (Lifestyle & Health) Lifestyle & Health
      • Consumer Products & Retail
      • Entertain­ment & Media
      • Health
      • Sports
      • Travel
      Close submenu (Policy & Public Interest) Policy & Public Interest
      • Policy & Public Interest
      Close submenu (People & Culture) People & Culture
      • People & Culture

      Study Finds Precision Medicine Initiatives Active in Broader Spectrum of Disease Areas and Datasets, But Not Without Technological Challenges

      Oracle Logo (PRNewsfoto/Oracle)

      News provided by

      Oracle

      Mar 06, 2018, 11:00 ET

      Share this article

      Share this article


      LAS VEGAS, March 6, 2018 /PRNewswire/ -- HIMSS CONFERENCE -- Oracle Health Sciences today announced the results of a new study that explores the current and planned status of precision medicine initiatives, associated challenges and the future impact of this discipline on life sciences and healthcare communities.

      Figure 13: Which subspecialties are included in your organization's precision medicine initiative? (Check all that apply; n = 120)
      Figure 13: Which subspecialties are included in your organization's precision medicine initiative? (Check all that apply; n = 120)
      Figure 6: What approach does your organization take for generating/completing precision medicine testing? (n = 120)
      Figure 6: What approach does your organization take for generating/completing precision medicine testing? (n = 120)
      Figure 11: What testing methods are currently included in your precision medicine initiative? (Check all that apply; n= 120) What testing methods do you plan to integrate into your Precision Medicine workflow in the next 24 months? (Check all that apply; n = 120)
      Figure 11: What testing methods are currently included in your precision medicine initiative? (Check all that apply; n= 120) What testing methods do you plan to integrate into your Precision Medicine workflow in the next 24 months? (Check all that apply; n = 120)
      Figure 15: What is the most significant factor in not pursuing a Precision Medicine initiative? (n = 50)
      Figure 15: What is the most significant factor in not pursuing a Precision Medicine initiative? (n = 50)
      Figure 13: Which subspecialties are included in your organization's precision medicine initiative? (Check all that apply; n = 120) Figure 6: What approach does your organization take for generating/completing precision medicine testing? (n = 120) Figure 11: What testing methods are currently included in your precision medicine initiative? (Check all that apply; n= 120) What testing methods do you plan to integrate into your Precision Medicine workflow in the next 24 months? (Check all that apply; n = 120) Figure 15: What is the most significant factor in not pursuing a Precision Medicine initiative? (n = 50)

      Conducted by GenomeWeb and sponsored by Oracle Health Sciences, the study revealed perspectives on the state of precision medicine from 316 scientists, researchers and other members of the life sciences and healthcare industries. While these communities have largely embraced the concept behind precision medicine — using the molecular makeup of patients in order to improve the diagnosis and treatment of disease — the survey captured a deeper look into the current and future statuses, approaches and implementations of precision medicine initiatives.

      Among its numerous findings, the survey discovered that the majority of organizations are active with precision medicine initiatives; 62 percent of the respondents participate in research activities to drive biomarker discovery or translational research, while another 12 percent would like to participate or are planning to do so in the next 12-24 months. Not surprisingly, oncology is still considered the disease area where precision medicine will have greatest impact. However, respondents also believe precision medicine will benefit several other disease areas, including cardiovascular disease, neurology and pediatrics, which are already included in some organizations' current initiatives.

      Early initiatives in precision medicine leveraged commercial partners to generate testing and results, but the new research highlights a shift of bringing more functionality in-house, with over 50 percent of respondents claiming to use either a hybrid or in-house approach.

      More than 72 percent of respondents from organizations with ongoing precision medicine initiatives said they are using next-generation sequencing (NGS) variant panels. There is a growing interest in additional data types, including more complex NGS, whole genome sequencing, and other omics data types. The study also found that nearly 80 percent hope they will be able to fully leverage large, more complex datasets to identify new insights and improve treatment recommendations by implementing these technologies in the future.

      The survey also found that the vast majority of respondents who are not currently planning such an effort indicated that they would see a benefit in pursuing one, and only 18 percent of the respondents indicated an insufficient benefit to their business. However, there are still a variety of challenges in developing a precision medicine initiative, with insufficient technical structures cited as a huge obstacle in organizations' ability to pursue precision medicine initiatives.

      "Precision medicine is vital to advancing medicine, and critical to its success is the underlying technology needed to manage the large volumes of data it requires," said Andy Alasso, Global Vice President, Oracle Health Sciences. "The findings revealed that while there is widespread interest in using more complex and diverse clinical and genomics data, there is also anxiety among researchers about deficiencies in their current technical infrastructure to handle such data.  This underscores the importance of platforms like Oracle Healthcare Foundation (OHF) to ensure the pace of innovation in precision medicine is not slowed by a lack of technical support."

      The study was conducted in the fall of 2017 by GenomeWeb and sponsored by Oracle Health Sciences. Data was gathered via an online survey taken by GenomeWeb readers from a variety of organizations including academic institutes, hospitals/medical centers, government agencies, pharmaceutical companies, contract research organizations, genomics service providers and clinical/reference labs. The total number of respondents surveyed was 316 and included primarily scientists and researchers, followed by people in executive or corporate management positions.

      Additional Resources

      • Oracle Healthcare Foundation
      • Full survey results

      About Oracle
      The Oracle Cloud offers complete SaaS application suites for ERP, HCM and CX, plus best-in-class database Platform as a Service (PaaS) and Infrastructure as a Service (IaaS) from data centers throughout the Americas, Europe and Asia. For more information about Oracle (NYSE:ORCL), please visit us at oracle.com

      About Oracle Health Sciences
      Oracle Health Sciences breaks down barriers and opens new pathways to unify people and processes, helping to bring new drugs to market faster. As the number one vendor in Life Sciences (IDC, 2017) and the number one provider of eClinical solutions (Everest Group, 2017), powered by the number one data management technology in the world (Gartner, 2017), Oracle Health Sciences is trusted by 29 of the top 30 pharma, 10 of the top 10 biotech, and 10 of the top 10 CROs for clinical trial and safety management around the globe.

      Trademarks
      Oracle and Java are registered trademarks of Oracle and/or its affiliates. Other names may be trademarks of their respective owners.

      SOURCE Oracle

      Modal title

      Also from this source

      Oracle Life Sciences AI Agents Bring AI-Assisted Operational Intelligence and Coordination to Clinical Trials

      Oracle Life Sciences AI Agents Bring AI-Assisted Operational Intelligence and Coordination to Clinical Trials

      Oracle today introduced Oracle Life Sciences AI Agents, a new agentic experience designed to help life sciences organizations apply intelligence and...

      New Oracle Primavera Cloud AI Capabilities Help Construction Teams Improve Project Planning and Risk Management

      New Oracle Primavera Cloud AI Capabilities Help Construction Teams Improve Project Planning and Risk Management

      Oracle today announced new enhancements to Oracle Primavera Cloud (OPC) designed to help engineering and construction teams easily find product...

      More Releases From This Source

      Explore

      Computer & Electronics

      Computer & Electronics

      Computer Software

      Computer Software

      Health Care & Hospitals

      Health Care & Hospitals

      Surveys, Polls and Research

      Surveys, Polls and Research

      News Releases in Similar Topics

      Contact PR Newswire

      • Call PR Newswire at 888-776-0942
        from 8 AM - 9 PM ET
      • Chat with an Expert
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices

      Products

      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content

      About

      • About PR Newswire
      • About Cision
      • Careers
      • Accessibility Statement
      • APAC
      • APAC - Simplified Chinese
      • APAC - Traditional Chinese
      • Brazil
      • Canada
      • Czech
      • Denmark
      • Finland
      • France
      • Germany
      • India
      • Indonesia
      • Israel
      • Italy
      • Japan
      • Korea
      • Mexico
      • Middle East
      • Middle East - Arabic
      • Netherlands
      • Norway
      • Poland
      • Portugal
      • Russia
      • Slovakia
      • Spain
      • Sweden
      • United Kingdom
      • Vietnam

      My Services

      • All New Releases
      • Platform Login
      • Data Privacy

      Do not sell or share my personal information:

      • Submit via [email protected] 
      • Call Privacy toll-free: 877-297-8921

      Contact PR Newswire

      Products

      About

      My Services
      • All News Releases
      • Platform Login
      • ProfNet
      Call PR Newswire at
      888-776-0942
      • Terms of Use
      • Privacy Policy
      • Information Security Policy
      • Site Map
      • RSS
      • Cookies
      Copyright © 2026 Cision US Inc.